レリッサ™

A randomized, placebo-controlled study was conducted on 100 subjects experiencing mild sleep problems (PSQI score >5) or individuals experiencing mildtomoderate mental stress. Mental and sleep health were measured at baseline and after 3 weeks of Relissa^TM supplementation (200 mg) (n=52) or placebo (n=48) twice a day.¹

After 3 weeks of administration, the study showed a significant increase in quality of sleep in subjects belonging to the intervention group when compared to baseline levels and to the placebo group (p<0.0001) (Figure 1). Moreover, authors highlighted a relevant beneficial effect in mental wellbeing (WEMWBS Score) (p<0.0001) (Figure 2), as well as a reduction on DASS Score indicators (p<0.0001).¹